Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-10 22:45:30 UTC
Update Date2022-09-22 17:45:00 UTC
HMDB IDHMDB0245703
Secondary Accession NumbersNone
Metabolite Identification
Common Name1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate
Description1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate, also known as molsidomin or corvaton, belongs to the class of organic compounds known as morpholines. These are organic compounds containing a morpholine moiety, which consists of a six-member aliphatic saturated ring with the formula C4H9NO, where the oxygen and nitrogen atoms lie at positions 1 and 4, respectively. Based on a literature review a significant number of articles have been published on 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate. This compound has been identified in human blood as reported by (PMID: 31557052 ). 1-ethoxy-n-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
5-[(Ethoxycarbonyl)amino]-3-(4-morpholinyl)-1,2,3-oxadiazolium inner saltChEBI
CAS 276ChEBI
CAS-276ChEBI
CorratonChEBI
CorunoChEBI
CorvatonChEBI
CovarsalChEBI
MolsiCareChEBI
MolsicorChEBI
MolsidolatChEBI
MolsidominChEBI
MolsidominaChEBI
MolsidominumChEBI
MorialChEBI
MorsydomineChEBI
MotazominChEBI
N-(Ethoxycarbonyl)-3-morpholinosydnone imineChEBI
N-Carboxy-3-morpholinosydnone imine ethyl esterChEBI
N-Ethoxycarbonyl-3-morpholinosydnonimineChEBI
SIN-10ChEBI
SydnopharmChEBI
1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidic acidGenerator
MolsidainHMDB
SIN 10HMDB
Molsidomin stadaHMDB
Von CT, molsidominHMDB
Molsi 1a pharmaHMDB
MolsibetaHMDB
SIN10HMDB
Molsi-azuHMDB
Fali corHMDB
MolsihexalHMDB
Molsi azuHMDB
Molsidomin ratiopharmHMDB
Fali-corHMDB
KorvatoneHMDB
Molsidomin heumannHMDB
Molsidomin-ratiopharmHMDB
Molsi purenHMDB
DuracoronHMDB
MTW-MolsidominHMDB
Heumann, molsidominHMDB
MolsiketHMDB
MTW MolsidominHMDB
Molsidomin von CTHMDB
CorpeaHMDB
Molsi-purenHMDB
Alpharma brand OF molsidomineHMDB
Molsidomine normon brandHMDB
MolsidominratiopharmHMDB
Stadapharm brand OF molsidomineHMDB
CT Arzneimittel brand OF molsidomineHMDB
1a Brand OF molsidomineHMDB
Azupharma brand OF molsidomineHMDB
Molsidomine ratiopharm brandHMDB
Normon brand OF molsidomineHMDB
Schwarz brand OF molsidomineHMDB
MolsidomineHMDB
Molsidomine aventis brandHMDB
Molsidomine salutas brandHMDB
Molsidomine schwarz brandHMDB
Molsidomine CT-arzneimittel brandHMDB
Sanol brand OF molsidomineHMDB
CT-Arzneimittel brand OF molsidomineHMDB
Hexal brand OF molsidomineHMDB
Merck dura brand OF molsidomineHMDB
Molsidomine heumann brandHMDB
Molsidomine stadapharm brandHMDB
Salutas brand OF molsidomineHMDB
Heumann brand OF molsidomineHMDB
Molsidomine betapharm brandHMDB
Aventis brand OF molsidomineHMDB
Molsidomine azupharma brandHMDB
Molsidomine hexal brandHMDB
Molsidomine MTW brandHMDB
Betapharm brand OF molsidomineHMDB
Ratiopharm brand OF molsidomineHMDB
MTW Brand OF molsidomineHMDB
Molsidomine 1a brandHMDB
Molsidomine alpharma brandHMDB
Molsidomine sanol brandHMDB
Ethyl N-[3-(morpholin-4-yl)-5H-1,2,3λ⁵-oxadiazol-5-ylidene]carbamic acidHMDB
Chemical FormulaC9H14N4O4
Average Molecular Weight242.235
Monoisotopic Molecular Weight242.101504947
IUPAC Name5-[(ethoxycarbonyl)azanidyl]-3-(morpholin-4-yl)-1,2,3λ⁵-oxadiazol-3-ylium
Traditional Name5-[(ethoxycarbonyl)azanidyl]-3-(morpholin-4-yl)-1,2,3λ⁵-oxadiazol-3-ylium
CAS Registry NumberNot Available
SMILES
CCOC(=O)[N-]C1=C[N+](=NO1)N1CCOCC1
InChI Identifier
InChI=1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3
InChI KeyXLFWDASMENKTKL-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as morpholines. These are organic compounds containing a morpholine moiety, which consists of a six-member aliphatic saturated ring with the formula C4H9NO, where the oxygen and nitrogen atoms lie at positions 1 and 4, respectively.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassOxazinanes
Sub ClassMorpholines
Direct ParentMorpholines
Alternative Parents
Substituents
  • Morpholine
  • Carbonic acid derivative
  • Dialkyl ether
  • Ether
  • Propargyl-type 1,3-dipolar organic compound
  • Organic 1,3-dipolar compound
  • Azacycle
  • Oxacycle
  • Organooxygen compound
  • Organonitrogen compound
  • Carbonyl group
  • Organic nitrogen compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Aliphatic heteromonocyclic compound
Molecular FrameworkAliphatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP-1ALOGPS
logP-1ChemAxon
logS-1.4ALOGPS
pKa (Strongest Acidic)7.99ChemAxon
pKa (Strongest Basic)-3.2ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area77.91 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity76.99 m³·mol⁻¹ChemAxon
Polarizability23.74 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+151.43630932474
DeepCCS[M-H]-149.04130932474
DeepCCS[M-2H]-181.92430932474
DeepCCS[M+Na]+157.34930932474
AllCCS[M+H]+153.532859911
AllCCS[M+H-H2O]+149.832859911
AllCCS[M+NH4]+157.032859911
AllCCS[M+Na]+158.032859911
AllCCS[M-H]-155.432859911
AllCCS[M+Na-2H]-155.632859911
AllCCS[M+HCOO]-155.832859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Predicted by Siyang on May 30, 202210.7876 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20225.71 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1308.0 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid269.0 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid119.1 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid164.8 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid56.9 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid374.6 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid535.0 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)107.2 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid770.3 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid308.8 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1289.9 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid283.4 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid286.3 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate376.6 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA266.3 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water112.5 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidateCCOC(=O)[N-]C1=C[N+](=NO1)N1CCOCC12681.4Standard polar33892256
1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidateCCOC(=O)[N-]C1=C[N+](=NO1)N1CCOCC11971.4Standard non polar33892256
1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidateCCOC(=O)[N-]C1=C[N+](=NO1)N1CCOCC11948.8Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate GC-MS (Non-derivatized) - 70eV, Positivesplash10-01dj-7910000000-63f8ea7ee27b88f0912f2021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate 10V, Positive-QTOFsplash10-0006-6490000000-c5e4bc21cb85b4e60a702016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate 20V, Positive-QTOFsplash10-000j-9220000000-abafa3380cf8a5a4d0bd2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate 40V, Positive-QTOFsplash10-000l-9400000000-daea7c7e4e60434835062016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate 10V, Negative-QTOFsplash10-0006-5290000000-6d4f7dd885c9fb6c59ad2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate 20V, Negative-QTOFsplash10-002n-9560000000-93fecea706c4877048ad2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 1-Ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate 40V, Negative-QTOFsplash10-052v-9000000000-a53b47a7b42292d341b52016-08-03Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
UrineDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB09282
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4090
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkMolsidomine
METLIN IDNot Available
PubChem Compound4238
PDB IDNot Available
ChEBI ID31861
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]